Antimicrobial Peptides Overcome Resistance as Antibiotic Adjuvants Through Multifaceted Mechanisms

Antimicrobial resistance (AMR) represents a critical global health crisis, with conventional antibiotics increasingly losing efficacy against a growing spectrum of resistant pathogens. The urgent demand for novel therapeutic strategies extends beyond discovering entirely new antibiotics, focusing instead on innovative approaches that can restore or significantly enhance the activity of existing drugs. Current standard-of-care often struggles with persistent infections, biofilm formation, and the rapid evolution of resistance mechanisms, leading to treatment failures and increased mortality. Antimicrobial peptides (AMPs) are emerging as a highly promising class of adjuvant therapeutics, capable of potentiating antibiotic efficacy through their unique, multifaceted mechanisms of action. This comprehensive review synthesizes the current understanding of how AMPs address the critical limitations of traditional antibiotics, offering a pathway to overcome drug resistance.

This comprehensive review systematically synthesizes recent advances in the field of antimicrobial peptides (AMPs) specifically as antibiotic adjuvants. The authors meticulously examined a broad range of studies to elucidate how AMPs overcome both intrinsic and acquired resistance phenotypes across clinically relevant Gram-negative and Gram-positive pathogens. The review explores various innovative strategies, including rationally engineered peptides, synthetic derivatives, peptide hybrids, and transmembrane mimetic approaches. Furthermore, it delves into the mechanisms by which AMPs enhance antibiotic activity and addresses the major translational bottlenecks hindering their clinical development, such as peptide instability and toxicity. The scope also covers advanced delivery systems like nanoparticles and liposomal platforms designed to mitigate these challenges.

Antimicrobial peptides (AMPs) significantly potentiate conventional antibiotic activity by targeting multiple bacterial vulnerabilities, thereby overcoming resistance. The review highlights several key, multifaceted mechanisms: > AMPs restore antibiotic efficacy primarily through direct membrane permeabilization, leading to bacterial cell death, and by effectively disrupting biofilm architecture, which is a major contributor to chronic infections and resistance. Additionally, AMPs demonstrate crucial roles in inhibiting bacterial efflux pumps, which actively expel antibiotics, and by neutralizing β-lactamases, enzymes that degrade common antibiotics like penicillin. They also modulate bacterial quorum sensing systems, interfering with bacterial communication and virulence, and exert immune regulation, enhancing the host's defense mechanisms. The review emphasizes that rationally engineered peptides, synthetic derivatives, and peptide hybrids have shown remarkable success in overcoming both intrinsic and acquired resistance phenotypes across a broad spectrum of clinically relevant Gram-negative and Gram-positive pathogens. Crucially, these peptide adjuvants enable significant dose reductions of often-toxic antibiotics and effectively circumvent pathogen persistence, thereby improving both pharmacodynamic outcomes and the overall therapeutic index of combination therapies.